Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer
      QxMD      Google Scholar   
Citation:
Cancer Control vol 30
Year:
2023
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
12
Parents:
382   391  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA189812, UG1CA232760, UG1CA233337, , U10CA180863 (Canadian Cancer Trials Group), U10CA180820, UG1CA233320 (ECOG-ACRIN), U10CA180888 (SWOG), P30 CA015083, UG1 CA233331  
Corr. Author:
 
Authors:
                           
Networks:
IWORC, LAPS-CT018, LAPS-IL036, LAPS-MN026, LAPS-OH007, METROMIN, OZARKS   
Study
NCCTG-N9741
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
colorectal cancer, patient-provided assessments, patient-reported outcomes, quality of life, performance status, prognostic models, Intergroup N9741